Loading clinical trials...
Loading clinical trials...
This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
GlaxoSmithKline
NCT02531880 · Epilepsy
NCT06097195 · Epilepsy
NCT07523048 · Major Depressive Disorder (MDD)
NCT06315322 · Childhood Absence Epilepsy, Juvenile Absence Epilepsy
NCT06388707 · Drug Resistant Epilepsy, Epilepsy, and more
GSK Investigational Site
Beverly Hills, California
GSK Investigational Site
Sherman Oaks, California
GSK Investigational Site
Temecula, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions